Pleiotropic effects of GLP-1 treatment on renal risk factors in type 2 diabetes

被引：0
|
作者：
Petersen, E. H. [1 ]
von Scholten, B. J. [1 ]
Lindhardt, M. [1 ]
Persson, F. [1 ]
Hansen, T. W. [1 ]
Rossing, P. [1 ,2 ]
机构：
[1] Steno Diabet Ctr, Gentofte, Denmark
[2] Novo Nordisk Fdn Ctr Metab Res, Copenhagen, Denmark
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
216
引用
收藏
页码：S110 / S111
页数：2
相关论文
共 50 条
  • [1] Renal effects of GLP-1 agonists in type 2 diabetes
    Elbert, Alicia
    Castellaro, Carlos
    Litwak, Leon
    Inserra, Felipe
    Wassermann, Alfredo
    Sinay, Isaac
    MEDICINA-BUENOS AIRES, 2022, 82 (04) : 576 - 590
  • [2] Impact of GLP-1 and GLP-1 Receptor Agonists on Cardiovascular Risk Factors in Type 2 Diabetes
    Verge, Danilo
    Lopez, Ximena
    CURRENT DIABETES REVIEWS, 2010, 6 (04) : 191 - 200
  • [3] Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment
    Zobel, Emilie Hein
    von Scholten, Bernt Johan
    Lindhardt, Morten
    Persson, Frederik
    Hansen, Tine Willum
    Rossing, Peter
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (01) : 162 - 168
  • [4] Pleiotropic effects of type 2 diabetes management strategies on renal risk factors
    Muskiet, Marcel H. A.
    Tonneijck, Lennart
    Smits, Mark M.
    Kramer, Mark H. H.
    Heerspink, Hiddo J. Lambers
    van Raalte, Danil H.
    LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (05): : 367 - 381
  • [5] GLP-1 for type 2 diabetes
    Ahren, Bo
    EXPERIMENTAL CELL RESEARCH, 2011, 317 (09) : 1239 - 1245
  • [6] Renal and cardiovascular effects of SGLT2 compared to GLP-1 in type 2 diabetes
    Dahm, Johannes B.
    AKTUELLE KARDIOLOGIE, 2024, 13 (06) : 426 - 426
  • [7] Exenatide, a GLP-1 agonist in the treatment of Type 2 diabetes
    Sennik, Devesh
    Ahmed, Fahad
    Russell-Jones, David
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2012, 7 (01) : 15 - 26
  • [8] GLP-1 gene delivery of type 2 for the treatment diabetes
    Oh, S
    Lee, M
    Ko, KS
    Choi, S
    Kim, SW
    MOLECULAR THERAPY, 2003, 7 (04) : 478 - 483
  • [9] Long acting GLP-1 for the treatment of type 2 diabetes
    Reichstetter, Sandra
    Castillo, Gerardo
    Perfetti, Riccardo
    Leahy, Mark
    Bolotin, Elijah
    DIABETES, 2007, 56 : A144 - A144
  • [10] GLP-1 analogues for treatment of type 2 diabetes in adolescents
    Veyder-Malberg, Caroline
    Furthner, Dieter
    Dalus, Christopher
    Maruszczak, Katharina
    Schneider, Anna-Maria
    Weghuber, Daniel
    MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (03) : 253 - 257
12345